Skip to main navigation

Top Navigation

Publications
Newsroom
Investors
Blog
Careers
Contact Us

mRNA Technology
Modalities
Pipeline
- Clinical Trials
- Therapeutic Areas
Citizenship
- Corporate Responsibility
About Us

Investors

IR Navigation

Overview
Stock Information
Corporate Governance
SEC Filings
Events & Presentations
Press Releases
Shareholder Resources
Statements & Perspectives

Investor Relations

Day High

Day Low

Volume

7:19 PM EDT
October 20, 2020

Copyright West LLC.
Minimum 15 minutes Delayed.

Press Releases

October 15, 2020

Moderna to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020

October 14, 2020

Moderna Receives Confirmation of Eligibility for Submission of Marketing Authorization Application to the European Medicines Agency for mRNA Vaccine Against COVID-19 (mRNA-1273)

October 13, 2020

Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)

View All Press Releases

Events

Oct 29, 2020 at 8:00 AM EDT

Moderna 3Q 2020 Earnings Call

View All Events

Presentations

Corporate Presentation

Annual R&D Day Presentation

Annual Science Day Presentation

Pipeline Program Detail

IR Contact

IR@modernatx.com

Email Alerts

Click Here to have company news delivered to your inbox

mRNA Technology
Modalities
Pipeline
Citizenship
About Us

Publications
Newsroom
Investors
Blog
Careers
Contact Us

Facebook
Twitter
Youtube
LinkedIn

Footer Menu - Bottom

© 2020 Moderna, Inc.
Privacy Policy
Join our Mailing List
Terms of Use

×

You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.